MDRX News and Press, Allscripts Healthcare Solutions Inc. From 05/06/23

2023-05-06 17:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-17 10:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-29 03:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2023 / Hagens Berman urges Veradigm Inc. (NASDAQ:MDRX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/MDRX Contact An Attorney Now: MDRX@hbsslaw.com 844-916-0895 Veradigm Inc...

SAN FRANCISCO, March 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. ( NASDAQ : MDRX ) investors who suffered substantial losses to submit your losses now . Veradigm Inc. ( MDRX ) Investigation : The investigation focuses ...

Veradigm ® (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book , a healthcare-centric market research and public opinion research and consulting company, has ranked Practice Fusion first for Allergy and Immunology and second...

2023-03-23 06:18:12 ET Veradigm ( NASDAQ: MDRX ) has revised its financial guidance for fiscal 2023, now expecting revenue in the range of $615M-$635M vs. $625M-$645M previously. Adjusted earnings outlook remains unchanged at $0.80 and $0.90 per share. In addition, Verad...

Veradigm Inc. (NASDAQ: MDRX), announced today an update on the status of its year-end audit procedures for 2022. As the Company disclosed on February 28, 2023, due to an expansion of year-end audit procedures, the Company filed with the SEC a Form 12b-25, extending the due date of its annual repo...

2023-03-19 12:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Top honors awarded in the 50+ physician category, placed in the top five across all physician group sizes Veradigm ® (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book , a healthcare-centric market research and pu...